Scholarly Index
Dominique Brémond‐Gignac
Inserm; 4,075 total citations; 394 total publications; best world rank #120
Inserm
4,075Total citations
394Total publications
35H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ocular Surface and Contact Lens | Lifetime | 725 | FR 15 | 96.18 |
| Corneal Surgery and Treatments | Lifetime | 792 | FR 25 | 95.07 |
| Ocular Infections and Treatments | Lifetime | 468 | FR 13 | 95.15 |
| Ophthalmology and Eye Disorders | Lifetime | 842 | FR 27 | 94.12 |
| Ocular Disorders and Treatments | Lifetime | 238 | FR 5 | 92.25 |
| Retinopathy of Prematurity Studies | Lifetime | 748 | FR 7 | 86.83 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 489 | FR 10 | 75.13 |
| Corneal Surgery and Treatments | 2021-2025 | 280 | FR 7 | 90.72 |
| Connexins and lens biology | 2021-2025 | 120 | FR 3 | 83.62 |
| Intraocular Surgery and Lenses | 2021-2025 | 583 | FR 15 | 85.57 |
| Ocular Surface and Contact Lens | 2021-2025 | 692 | FR 8 | 85.82 |
| Retinal Development and Disorders | 2021-2025 | 708 | FR 19 | 83.11 |
| Ocular Infections and Treatments | 2021-2025 | 384 | FR 6 | 76.58 |
| Ocular Disorders and Treatments | 2021-2025 | 220 | FR 6 | 62.45 |
| Retinopathy of Prematurity Studies | 2021-2025 | 802 | FR 9 | 52.30 |
| Developmental Biology and Gene Regulation | 2021-2025 | 544 | FR 25 | 47.08 |